Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 11 of 86 Results 101 to 110 of 858
Individualised risk prediction model for exacerbations in patients with severe asthma: Protocol for a multicentre real-world risk modelling study
BMJ Open, vol. 13, no. 3, e070459Contributions to Journals: ArticlesApplication of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
npj Primary Care Respiratory Medicine, vol. 33, no. 1, 9Contributions to Journals: ArticlesEnding the reign of short-acting β2-agonists in Australia?
TSANZSRS 2023, pp. 39Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1111/resp.14459
Demographic and Clinical Characteristics of Patients with Severe Asthma in the Asian Pacific Region: data from the International Severe Asthma Registry (ISAR)
APSR 2022, pp. 3-413Contributions to Journals: AbstractsDupilumab sustains improvements in clinical efficacy and reductions in OCS use in patients with severe, OCS-dependent asthma: LIBERTY ASTHMA TRAVERSE study
APSR 2022, pp. 3-413Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1111/resp.14433
Ending the reign of short-acting β2-agonists in Australia?
APSR 2022, pp. 3-413Contributions to Journals: AbstractsThe association of short acting β2-agonist overuse with asthma control and severe exacerbations: an Australian perspective
APSR 2022, pp. 3-413Contributions to Journals: AbstractsDefining clinical subtypes of adult asthma using electronic health records: analysis of a large UK primary care database with external validation
International Journal of Medical Informatics, vol. 170, 104942Contributions to Journals: ArticlesEffect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK Database Study
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 2, pp. 532-543Contributions to Journals: ArticlesSustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
EAACI HYBRID CONGRESS 2022, pp. 237Contributions to Journals: Abstracts